Dr Andreas Bender is a Reader for Molecular Informatics with the Centre for Molecular Informatics at the University of Cambridge, where he is leading a group of about 20 postdocs, PhD and graduate students and academic visitors. Recent focus areas of his group include the modelling of compound combinations, in silico target prediction for mode-of-action analysis and compound selectivity modelling, as well as the utilization of gene expression data for compound selection and drug repurposing.
Andreas received his PhD from the University of Cambridge (UK) and subsequently he joined the Novartis Institutes for BioMedical Research in Cambridge/MA as a Presidential Postdoctoral Fellow. He received the EFMC Prize for a Young Medicinal Chemist in Academia 2010, as well as the Prize for Innovation in Medicinal and Pharmaceutical Chemistry by the German Chemical and Pharmaceutical Societies (GDCh and DPhG) and the Bayer Early Excellence in Science Award in 2011. In 2013 Andreas has been awarded an ERC Starting Grant to model mixture effects of chemical structures in biological systems, an area currently very little understood.